Trending/Journal of the National Cancer Institute. Ruth Lupu
Mayo Clinic-led Team Identifies Master Switch for Cancer-Causing HER2 Protein
ROCHESTER, Minn. — Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is…
No information found.
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community